Sionna Therapeutics, Inc.

Contributing Author

Recent Articles by Sionna Therapeutics, Inc.

Jun-06	Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model SION GlobeNewswire
Jun-04	Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis SION GlobeNewswire
Jun-03	Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference SION GlobeNewswire
May-22	Sionna Therapeutics to Present Preclinical Data During Oral Session at the 48th European Cystic Fibrosis Conference SION GlobeNewswire
May-12	Sionna Therapeutics Reports First Quarter 2025 Financial Results SION GlobeNewswire